000 | 01192 a2200361 4500 | ||
---|---|---|---|
005 | 20250513193548.0 | ||
264 | 0 | _c19991124 | |
008 | 199911s 0 0 eng d | ||
022 | _a0014-5793 | ||
024 | 7 |
_a10.1016/s0014-5793(99)01259-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichelle, M | |
245 | 0 | 0 |
_aUrinary isoprostane excretion is not confounded by the lipid content of the diet. _h[electronic resource] |
260 |
_bFEBS letters _cOct 1999 |
||
300 |
_a259-62 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aDiet, Fat-Restricted _xadverse effects |
650 | 0 | 4 |
_aDietary Fats _xpharmacology |
650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
650 | 0 | 4 | _aF2-Isoprostanes |
650 | 0 | 4 | _aFasting |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLipid Peroxidation |
650 | 0 | 4 | _aMale |
700 | 1 | _aTurini, M E | |
700 | 1 | _aGuidoux, R | |
700 | 1 | _aTavazzi, I | |
700 | 1 | _aMétairon, S | |
700 | 1 | _aFay, L B | |
773 | 0 |
_tFEBS letters _gvol. 459 _gno. 2 _gp. 259-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-5793(99)01259-4 _zAvailable from publisher's website |
999 |
_c10475079 _d10475079 |